135,862 Shares of Mirion Technologies, Inc. $MIR Bought by Moody Aldrich Partners LLC

Moody Aldrich Partners LLC purchased a new position in shares of Mirion Technologies, Inc. (NYSE:MIR) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 135,862 shares of the company’s stock, valued at approximately $1,918,000. Moody Aldrich Partners LLC owned about 0.05% of Mirion Technologies at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of MIR. Versant Capital Management Inc lifted its position in Mirion Technologies by 42.8% in the third quarter. Versant Capital Management Inc now owns 2,505 shares of the company’s stock valued at $35,000 after purchasing an additional 751 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Mirion Technologies by 65.1% during the third quarter. GAMMA Investing LLC now owns 2,579 shares of the company’s stock valued at $36,000 after purchasing an additional 1,017 shares during the period. Assetmark Inc. grew its holdings in shares of Mirion Technologies by 8,123.8% in the first quarter. Assetmark Inc. now owns 3,454 shares of the company’s stock worth $64,000 after purchasing an additional 3,412 shares during the last quarter. GK Wealth Management LLC bought a new position in shares of Mirion Technologies in the third quarter worth approximately $75,000. Finally, Nykredit A S bought a new position in shares of Mirion Technologies in the second quarter worth approximately $137,000. 78.51% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on MIR shares. B. Riley Financial decreased their target price on shares of Mirion Technologies from $29.00 to $27.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Morgan Stanley dropped their price target on shares of Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating for the company in a research report on Monday, July 13th. Citigroup cut their price target on shares of Mirion Technologies from $28.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Jefferies Financial Group assumed coverage on shares of Mirion Technologies in a report on Thursday, September 3rd. They issued a “buy” rating and a $20.00 price target on the stock. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $23.00 price objective on shares of Mirion Technologies in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $25.12.

Key Mirion Technologies News

Here are the key news stories impacting Mirion Technologies this week:

• Positive Sentiment: Revenue exceeded expectations and surged year over year. Third-quarter revenue rose 24.5% to $277.8 million, ahead of the approximately $275.4 million analyst consensus. Mirion Technologies Profit Advances in Q3
• Positive Sentiment: Nuclear-related demand was a major bright spot. Reports highlighted a 105% increase in nuclear orders, while management raised its outlook, strengthening the growth narrative and likely supporting investor confidence. Mirion Technologies Q3 2026 Earnings
• Positive Sentiment: Profitability improved substantially from the prior year. Adjusted earnings were $0.12 per share, matching estimates but increasing from $0.01 a year earlier. Management’s earnings call provided investors with additional detail on the quarter and the company’s outlook. Mirion Technologies Q3 2026 Earnings Call Transcript
• Neutral Sentiment: Unusually heavy call-option activity indicated bullish positioning. Investors purchased 13,224 call options, 576% above typical daily volume. Options activity can amplify short-term momentum, but it does not guarantee sustained buying or reflect the company’s fundamental value.
• Negative Sentiment: Earnings did not beat expectations. Despite the revenue outperformance, per-share earnings matched consensus rather than exceeding it. The unchanged adjusted earnings figure amid strong revenue growth may limit the stock’s upside if investors focus on margin expansion and valuation.

Mirion Technologies Trading Up 8.5%

MIR opened at $16.72 on Thursday. Mirion Technologies, Inc. has a one year low of $14.04 and a one year high of $30.28. The company has a debt-to-equity ratio of 0.64, a current ratio of 3.20 and a quick ratio of 2.63. The business has a 50 day simple moving average of $15.56 and a two-hundred day simple moving average of $18.44. The firm has a market capitalization of $4.16 billion, a price-to-earnings ratio of 167.17 and a beta of 1.10.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $0.12 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.12. Mirion Technologies had a return on equity of 6.59% and a net margin of 2.39%. The firm had revenue of $277.80 million for the quarter, compared to analyst estimates of $275.35 million. During the same period last year, the company earned $0.01 EPS. The business’s quarterly revenue was up 24.5% compared to the same quarter last year. Analysts predict that Mirion Technologies, Inc. will post 0.55 EPS for the current year.

Mirion Technologies Profile

Mirion Technologies, Inc develops, manufactures and supplies radiation detection, measurement and analysis technologies. Its products are designed to detect and measure ionizing radiation, monitor exposure and contamination, and support the safe management of radioactive materials and environments.

The company serves a range of end markets, including nuclear power, healthcare, defense and national security, scientific research, industrial operations and laboratories. Its offerings include radiation detectors, dosimetry systems, spectroscopy and monitoring equipment, radiation safety software, and related services.